Yes. Veracyte was formerly owned by 1 private investor.
Veracyte is headquartered in South San Francisco, California.
Veracyte disclosed revenue of 446M USD for 2024 and 361M USD for 2023.
Veracyte has 824 employees.
Veracyte is a life science company.
Veracyte was founded in 2006.
6000 Shoreline Court, Suite 300,
South San Francisco, California
94080
United States,
(650) 243-6300
www.veracyte.com
Veracyte is a molecular cytology company. Veracyte seeks to use molecular cytology to improve diagnosis with the promise to help physicians and patients make more informed treatment decisions. Veracyte solution will utilize molecular biomarkers on cytology samples to characterize nodules as benign or suspicious of malignancy. Veracyte was founded in 2006 and is based in South San Francisco, California.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.6/yr) | # | 1 | 2 | - | - | 1 | - | 4 |
| vol | $21M | $893M | $70M | $984M | ||||
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 4 | ||||||||
| Financial | Deals |
|---|---|
|
Goldman Sachs |
2 |
|
Morgan Stanley |
1 |
| Legal | Deals |
|---|---|
|
Fenwick & West |
3 |
|
Latham & Watkins |
1 |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
